Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$25.95 - $36.95 $74,346 - $105,861
2,865 Added 568.45%
3,369 $93,000
Q4 2022

Feb 13, 2023

BUY
$24.79 - $30.86 $12,395 - $15,430
500 Added 12500.0%
504 $13,000
Q3 2022

Nov 14, 2022

BUY
$24.62 - $32.44 $98 - $129
4 New
4 $0
Q1 2022

May 13, 2022

SELL
$26.68 - $41.63 $53 - $83
-2 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$33.67 - $43.44 $19,090 - $24,630
-567 Reduced 99.65%
2 $0
Q3 2021

Nov 12, 2021

BUY
$30.65 - $35.68 $17,439 - $20,301
569 New
569 $19,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.42B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.